The Personalized Parkinson Project De Novo Cohort
Trial
N/A
Active, not recruiting
March 23, 2025
FMRI-neurofeedback in Parkinson's Disease
Trial
N/A
Recruiting
March 23, 2025
Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy
Trial
N/A
Unknown
March 23, 2025
Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's Disease
Trial
N/A
Completed
March 18, 2025
Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
Trial
N/A
Recruiting
March 18, 2025
Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study
Trial
Phase 2
Withdrawn
March 18, 2025
Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
Trial
Phase 2
Completed
March 17, 2025
The Relationship Between Upper Extremity Function and Balance and Functional Mobility in Parkinson's Disease
Trial
N/A
Recruiting
March 17, 2025
Reliability and Validity of DIDA-Q in Parkinson's Disease
Trial
N/A
Completed
March 16, 2025
LFP Sensing From Directional Leads in the Acute Clinical Setting
Trial
N/A
Enrolling by invitation
March 16, 2025
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Trial
N/A
Recruiting
March 16, 2025
High-intensity Functional Training on Functional and Cognitive Performance in People with Parkinson's Disease.
Trial
N/A
Recruiting
March 16, 2025
Longitudinal Outcomes of DBS in PD
Trial
N/A
Terminated
March 13, 2025
Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)
Trial
N/A
Active, not recruiting
March 13, 2025
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
Trial
N/A
Enrolling by invitation
March 12, 2025
Istradefylline Effect Protocol on Parkinson's Disease Tremor
Trial
Phase 4
Completed
March 12, 2025
Colorado Oral Strengthening Device
Trial
N/A
Completed
March 12, 2025
The ADAPT-study: Measuring Physical Performance Using Wearable Sensors in Parkinson's Disease and COPD (ADAPT)
Trial
N/A
Completed
March 11, 2025